Thirty-two years' experience of treating fulminant hepatitis in a Japanese single center.

Prognosis of our patients with FH and LOHF has not improved probably because of aging and the increasing proportion of etiologies with poor prognosis and difficult-to-treat patients without response to medications regardless of advancement of clinical management including artificial liver support devices and LT. This article is protected by copyright. All rights reserved.